SCHEMBL30898156

SCHEMBL30898156

COC(=C=O)/C=C/CN1CCC2(CC1)CCN(C(=O)OC(C)(C)C)CC2

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.41
▸ CYP3A4 P08684 2/20 0.37
▸ TSHR P16473 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ GPR119 Q8TDV5 5/20 0.37
▸ USP2 O75604 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ EPHX2 P34913 1/20 0.34
▸ CYP11B2 P19099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30898090 0.94 CYP11B2 (0.39) CYP2D6ALDH1A1GPR119USP2CYP1A2
SCHEMBL30898219 0.93 CYP2D6 (0.38) CYP2D6CYP3A4TSHRALDH1A1MAPK1
SCHEMBL30898045 0.92 SCD5 (0.36) CYP2D6CYP3A4ALDH1A1CYP2C19HSD17B10
SCHEMBL30898215 0.92 GPR183 (0.37) CYP2D6ALDH1A1USP2SMN1; SMN2CYP1A2
SCHEMBL30898235 0.91 SCD5 (0.38) CYP2D6CYP3A4ALDH1A1GPR119USP2
SCHEMBL30898144 0.90 RORC (0.38) CYP2D6ALDH1A1GPR119USP2SMN1; SMN2
SCHEMBL30898023 0.89 RORC (0.38) CYP2D6ALDH1A1USP2SMN1; SMN2CYP1A2
SCHEMBL30898071 0.84 RORC (0.34) GPR119USP2SMN1; SMN2EPHX2CYP11B2
SCHEMBL30898111 0.82 MGLL (0.42) GPR119USP2SMN1; SMN2NAMPT
SCHEMBL30898043 0.82 GPR183 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024083086-A1 BICYCLIC DERIVATIVE INTEGRIN INHIBITOR 上海如凌生物医药有限公司 2024-04-25 — — WO disclosed
CN-117903171-A Integrin inhibitors of a class of bicyclic derivatives 上海如凌生物医药有限公司 2024-04-19 — — CN disclosed
Send feedback